Please provide your email address to receive an email when new articles are posted on . Aura Biosciences announced positive visual acuity results from a phase 1b/2 trial of its cancer drug AU-011 in ...

A four-year clinical study has found that while early treatment of diabetes-related eye disease using anti-vascular endothelial growth factor (anti-VEGF; aflibercept) slowed progression to severe ...